T cell responses to human type ii collagen in patients with rheumatoid arthritis and healthy controls

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1210-1218

  Snowden, Neil ^a,b   Reynolds, Irena ^a   Morgan, Keith ^c   Holt, Lennox ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c Hope Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CARTILAGE DEGENERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; JOINT DEGENERATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION; THYMUS;

EID: 0030883484     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199707)40:7<1210::AID-ART4>3.0.CO;2-T     Document Type: Article

References (46)

1. Morgan K: What do anti-collagen antibodies mean? Ann Rheum Dis 49:62-65, 1990
2. Klareskog L, Olsson T: Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents. Immunol Rev 118:285-309, 1990
3. 125I-radioimmunoassay. Arthritis Rheum 26:832-840, 1983
4. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL: Incidence of antibodies to native and denatured cartilage collagens (types II, IX and XI) and to type 1 collagen in rheumatoid arthritis. Ann Rheum Dis 46:902-907, 1987
5. Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM: Anti-type II collagen antibodies in RA. Tissue Antigens 23:263-269, 1984
6. Klimiuk PS, Clague RB, Collins I, Ayad S, Phinn, Holt PLJ: Autoimmunity to native type II collagen - a distinct subset of rheumatoid arthritis. J Rheumatol 12:865-870, 1985
7. Rowley MJ, Tait B, Doran T, Emery P, Mackay IR: Associations between HLA and antibodies to collagen in rheumatoid arthritis. Ann Rheum Dis 49:578-581, 1990
8. Trentham DE, Dynesius RA, Rocklin RE, David JR: Cellular sensitivity to collagen in RA. N Engl J Med 299:327-332, 1978
9. Stuart JM, Postlethwaite AE, Townes AS, Kang AH: Cell mediated immunity to collagen and collagen α chains in RA and other rheumatic diseases. Am J Med 69:13-18, 1980
10. Trentham DE, Kammer GM, McCune WJ, David JR: Autoimmunity to collagen: a shared feature of psoriatic and rheumaotid arthritis. Arthritis Rheum 24:1363-1369, 1981
11. Solinger AM, Bhatnagar R, Stobo JD: Cellular, molecular and genetic charecteristics of T cell reactivity to collagen in man. Proc Natl Acad Sci USA 78:3877-3881, 1981
12. Sigal LH, Johnston SL, Philips PE: Cellular immune responses to cartilage components in RA and OA: a review and report of a study. Clin Exp Rheumatol 6:59-66, 1988
13. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H: Evidence in support of a self-perpetuating HLA-DR dependent delayed type reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 79:3632-3640, 1982
14. Desai BV, Dixit S, Pope RM: Limited proliferative response to type II collagen in rheumatoid arthritis. J Rheumatol 16:1310-1314, 1989
15. Londei M, Savill C, Verhoef A, Brennan F, Leech Z, Duance V, Maini RN, Feldmann M: Persistence of collagen type II specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 86:636-642, 1989
16. Salmon M, Gaston JSH: The role of T-lymphocytes in rheumatoid arthritis. Br Med Bull 51:332-345, 1995
17. Andersson M, Holmdahl R: Analysis of collagen reactive T cells in the mouse. I. Different regulation of autoreactive vs non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 20:1061-1066, 1990
18. Lacour M, Rudolphi U, Schlesier M, Peter HH: Letter to the editor. Eur J Immunol 21:1092, 1991
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
20. Cooper AL, Snowden N, Wooley DE: IgE antibodies specific for cartilage collagens types II, IX and XI in rheumatoid arthritis. Scand J Rheumatol 22:207-214, 1993
21. Williams RO, Williams DG, Maini RN: Anti-type II collagen ELISA: increased disease specificity following removal of anionic contaminants from salt fractionated type II collagen. J Immunol Methods 147:93-100, 1992
22. Yan T, Burkhardt H, Ritter T, Broker B, Mann KH, Bertling WM, von der Mark K, Emmrich F: Specificity and T cell receptor β chain usage of a human collagen type II-reactive T cell clone derived from a healthy individual. Eur J Immunol 22:51-56, 1992
23. Ku G, Kronenberg M, Peacock DJ, Tempst P, Banquerigo ML, Braun BS, Reeve JR, Brahn E: Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Eur J Immunol 23:591-599, 1993
24. Myers LK, Cooper SW, Terato K, Seyer JM, Stuart JM, Kang AH: Identification and characterization of a tolerogenic T cell determinant within residues 181-209 of chick type II collagen. Clin Immunol Immunopathol 75:33-38, 1995
25. Worthington J, Morgan K: Epitope mapping using synthetic peptides. In, Peptide Antigens: A Practical Approach. Oxford, UK, IRL Press, 1993
26. Wucherpfennig KW, Weiner HL, Hafler DA: T-cell recognition of myelin basic protein. Immunol Today 12:277-281, 1992
27. Harrison LC, Honeyman MC, DeAzipurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relationship between humoral and cellular immunity in subjects at risk of insulin dependent diabetes. Lancet 341:1365-1369, 1993
28. Ewins DL, Barnett PS, Ratanachaiyavong S, Sharrock C, Lanchbury J, McGregor AM, Banga JP: Antigen-specific T cell recognition of affinity purified and recombinant thyroid peroxidase in autoimmune thyroid disease. Clin Exp Immunol 90:93-98, 1992
29. Kitas GD, Salmon M, Farr M, Young SP, Bacon PA: T-cell functional defects in rheumatoid arthritis - intrinsic or extrinsic? J Autoimmun 1:334-351, 1991
30. Life PF, Viner NJ, Bacon PA, Gaston JSH: Synovial fluid antigen presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis. Clin Exp Immunol 79:189-194, 1990
31. Ofosu-Appiah W, Warrington RJ, Morgan K, Wilkms JA: Lymphocyte extracellular matrix interactions: induction of interferon by connective tissue components. Scand J Immunol 29:517-525, 1989
32. Shimuzu Y, Shaw S: Lymphocyte interaction with extracellular matrix. FASEB J 5:2292-2299, 1991
33. Collins TL, Kassner PD, Bierer BE, Burakott SJ: Adhesion recptors in lymphocyte activation. Curr Opin Immunol 6:385-393, 1994
34. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ: Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 32: 1087-1092, 1989
35. Barker RN, Elson CJ: Multiple self epitopes on the rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur J Immunol 24:1578-1582, 1994
36. Elson CJ, Barker RN, Thompson SJ, Williams NA: Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 16:71-76, 1995
37. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ: T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139-1143, 1994
38. Ferber I, Schonrich G, Schenkel J, Mellor AL, Hammerling GJ, Arnold B: Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674-677, 1994
39. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G: Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 14:203-207, 1993
40. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P: Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 39:1720-1727, 1996
41. Jenkins MK: The role of cell division in the induction of clonal anergy. Immunol Today 13:69-74, 1992
42. Perieira RS, Black CM, Duancc VC, Jones VE, Jacoby RK, Welsh KI: Disappearring collagen antibodies in rheumatoid arthritis. Lancet 2:501-502, 1985
43. Morgan K, Clague RB, Reynolds I, Davis M: Antibodies to type II collagen in early rheumatoid arthritis. Br J Rheumatol 32:333-335, 1993
44. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730, 1993
45. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral type II collagen treatment in early rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial. Arthritis Rheum 39:41-51, 1996
46. Barnett ML, Combitchi D, Trentham DE: A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum 39:623-628, 1996